• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Industrials·688101.SS
Share

Suntar Environmental Technology Co., Ltd. Stocks

CN¥ 14.18Last Updated 12.10.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 708.96M

CN¥ 14.18
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Suntar Environmental Technology Co., Ltd., established in 2005 and headquartered in Xiamen, China, specializes in delivering advanced industrial membrane separation solutions across the nation. The company's extensive service portfolio includes ceramic, spiral, and PP/PE membrane separation techniques, alongside sophisticated offerings such as flow-cel membrane technology, solvent recovery systems, membrane bioreactor (MBR) applications, continuous chromatography separation, and ion exchange processes. Additionally, Suntar manufactures and supplies a variety of specialized products, including ceramic, spiral wound, hollow fiber, and spiral membranes, as well as laboratory equipment and Integrated Membrane Bioreactors (IMBRs). Their tailored solutions cater to a diverse clientele within the biological, chemical engineering, pharmaceutical, and food and beverage sectors.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued on EV/

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

12.10.2026 18:58

Oppenheimer recommends buying Fastly stock ahead of the earnings report and the release of the iconic game GTA

12.10.2026 18:03

Shares of Nebius' competitor surged following news of a contract with Anthropic

12.10.2026 17:57

China's CXMT has unsettled investors in Micron and Samsung, causing their stock prices to fall. What's going on?

12.10.2026 16:53

Jennifer Garner's company could see its stock price rise by 50%: Freedom has identified unaccounted-for growth drivers

12.10.2026 16:43

"The bar is being raised for any IPO": What signal does the cancellation of Firmus's listing send to the market?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026